Bruton’s tyrosine kinase inhibitors in primary central nervous system lymphoma—evaluation of anti-tumor efficacy and brain distribution

BACKGROUND: Primary central nervous system lymphoma (PCNSL) is an aggressive lymphoma confined to central nervous system. Current treatments including surgery, chemotherapy and whole-brain radiotherapy often fail to achieve satisfactory effect, especially in elderly. As a regimen in targeted therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Haifeng, Kong, Haiying, Li, Cong, Dong, Xiaowu, Wu, Yizhe, Zhuang, Yuxin, Han, Shuiyun, Lei, Tao, Yang, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798964/
https://www.ncbi.nlm.nih.gov/pubmed/35116520
http://dx.doi.org/10.21037/tcr-21-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798964/
https://www.ncbi.nlm.nih.gov/pubmed/35116520
http://dx.doi.org/10.21037/tcr-21-50

Ejemplares similares